N6-Benzoyl-2'-O-methyladenosine is a chemically modified nucleoside derivative. It features a benzoyl group at the N6 position of the adenine base and a methoxy group at the 2' position of the ribose sugar. This specific modification pattern makes it a key building block in oligonucleotide synthesis, particularly for the preparation of antisense oligonucleotides and small interfering RNAs (siRNAs). Its primary application is as a protected phosphoramidite monomer in solid-phase oligonucleotide synthesis. The N6-benzoyl group protects the exocyclic amine during synthesis, while the 2'-O-methyl modification enhances the nuclease resistance and binding affinity of the resulting oligonucleotide. These properties are crucial for developing therapeutic nucleic acids with improved stability and efficacy for targeting specific genes. This compound is a high-value specialty chemical used extensively in pharmaceutical research and development for creating next-generation genetic medicines. It is not a general-purpose synthetic building block but a dedicated reagent for the life sciences and drug discovery sector.